Showing 1931-1940 of 2526 results for "".
- Envision Invites Students Across the Country Who are Blind or Visually Impaired to Prepare for College and Careers with Annual Level Up Technology Camphttps://modernod.com/news/envision-invites-students-across-the-country-who-are-blind-or-visually-impaired-to-prepare-for-college-and-careers-with-annual-level-up-technology-camp/2480791/Envision has opened high school registration for the 2022 Level Up Technology Camp designed to equip students with vision loss with academic, professional and interpersonal skills needed for college and beyond. High school students with vision loss across the United States ar
- Study Lays Foundation for Establishing Base Editing as a One-Time, Durable Treatment for Inherited Retinal Degenerationhttps://modernod.com/news/study-lays-foundation-for-establishing-base-editing-as-a-one-time-durable-treatment-for-inherited-retinal-degeneration/2480766/A new University of California, Irvine-led study indicates base editing may provide long-lasting retinal protection and prevent vision deterioration in patients with inherited retinal degeneration, specifically in Leber congenital amaurosis (LCA) patients. “Our findings demo
- Study: People with Vision Impairments up to Four Times More Likely to Suffer Mental Health Problemshttps://modernod.com/news/study-people-with-vision-impairments-up-to-four-times-more-likely-to-suffer-mental-health-problems/2480757/Research by international development organization Sightsavers, University of Ilorin, and the Kogi State Ministry of Health, in Nigeria has revealed links between vision impairment and poor mental health.
- AXIM Biotech Develops Rapid Quantitative Tear Test for MMP-9, An Inflammatory Biomarker of Dry Eye Diseasehttps://modernod.com/news/axim-biotech-develops-rapid-quantitative-tear-test-for-mmp-9-an-inflammatory-biomarker-of-dry-eye-disease/2480753/AXIM Biotechnologies announced that it has successfully developed a rapid quantitative tear test for MMP-9, an inflammatory biomarker for dry eye disease. "Dry eye disease, though widespread, is under-diagnosed, in part because symptoms do not always
- Luneau Technology Launches as 'Visionix' to Manufacture and Sell Optovue, Visionix, Briot and Weco Brandshttps://modernod.com/news/luneau-technology-launches-as-visionix-to-manufacture-and-sell-optovue-visionix-briot-and-weco-brands/2480736/Luneau Technology Group recently announced that it will take on 'Visionix' as its official global name beginning March 31, 2022, unveiling a combined booth at Vision Expo East. As mentioned in the recent global announcement, 'Optovue' will transition to a product brand f
- Penn Researchers Develop Gene Therapy that Restores Dim-Light Vision in Dogshttps://modernod.com/news/penn-researchers-develop-gene-therapy-that-restores-dim-light-vision-in-dogs/2480723/In the journal Proceedings of the National Academy of Sciences, University of Pennsylvania researchers reported a major advance: a gene therapy that returns night vision to dogs born with congenital stationary night blindness
- New Multi-Language Options Now Available on Reichert.comhttps://modernod.com/news/new-multi-language-options-now-available-on-reichertcom/2480719/Reichert Technologies, a business unit of Ametek, has announced that Reichert.com is now available in five new language options: Chinese, French, German, Italian, and Spanish. Putting customers first will always be Reichert’s main focus. This new capability will help make the information on
- Evmann Creates Roadmap to Facilitate its Development into a €1 Billion Global Companyhttps://modernod.com/news/evmann-creates-roadmap-to-facilitate-its-development-into-a-eur1-billion-global-company/2480714/Dutch Evmann Investments Holding, the parent company of VSY Biotechnology, organized its 2022 Global Leadership Meeting last week in line with its strategic plans to become a "unicorn" company. "Unicorn" is a term used in the venture capital industry to describe 
- Visus Therapeutics Announces Appointment of Julia Williams as Vice President of Clinical and Medical Affairs and Expansion of Irvine Co-Headquartershttps://modernod.com/news/visus-therapeutics-announces-appointment-of-julia-williams-as-vice-president-of-clinical-and-medical-affairs-and-expansion-of-irvine-co-headquarters/2480703/Visus Therapeutics announced the appointment of eye care industry veteran Julia Williams as vice president of clinical and medical affairs. The company also announced the expansion of its Irvine co-headquarters in the University of California-Irvine Research Park, including the establishment
- Théa Completes its Acquisition of Akorn’s Branded Ophthalmic Productshttps://modernod.com/news/thea-completes-its-acquisition-of-akorns-branded-ophthalmic-products/2480688/Théa Pharma announced the completion of its previously announced acquisition of seven branded ophthalmic products from Akorn. The transaction expands Théa’s eye care portfolio in the United States. Financial terms of the deal were not disclosed. &